Kintara Therapeutics, Inc. (KTRA) has a market capitalization of $11.99M and trades at $0.22. The 52-week range is 0.2049-26.214998.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-1.21.
The stock has a beta of 0.81, operates in the Healthcare sector.
